Abstract

Background

Hepatitis A (HAV) and hepatitis B (HBV) are hyperendemic among the indigenous population of Papua New Guinea (PNG), but little is known of the recent epidemiology of these diseases among the large number of expatriates living in PNG.

Methods

The authors sought to determine the prevalence and rate of acquiring HAV and HBV antibody markers in expatriate missionaries, using a cross-sectional serosurvey method.

Results

The authors entered 501 subjects into the study; the subjects had a mean time in-country of 100 months. Evidence for past infection with HAV was found in 47% of subjects (n=179) who had not received gamma globulin. Being a health care worker did not increase the probability of being HAV positive, but being a houseparent who cared for missionary children did (p=.06). Fifty percent of children <21 years old had positive HAV markers. Having a family member with a history of supposed “hepatitis” significantly increased the probability of being HAV positive (p=.0001). Evidence for past infection with HBV was found in 9.5% of subjects (n=46). Among those with evidence of past infection, 31% were <16 years old. Both infections are acquired more rapidly in children than in adults, and HAV is acquired more rapidly than HBV.

Conclusions

Expatriates living in the hyperendemic setting of PNG have high seroprevalence rates for evidence of infection with HAV (47%) and HBV (9.5%). Children have rates of infection equal to, or greater than, adults in this setting. Expatriates living in countries with high endemic rates of HAV and HBV infection are at high risk of acquiring these infections and should be targeted to receive information about the risks of disease and the benefits of immunization.

References

1
Woodfield
DG
Oraka
RE
Nelson
M.
Australia antigen in Papua New Guinea
.
Med J Aust
 
1972
;
2
:
469
472
.
2
Simons
MJ
Binns
CW
Malcolm
LA
, et al.
Australia antigen frequencies in two groups of highland New Guineans
.
P N G Med J
 
1972
;
15
:
91
97
.
3
Blumberg
BS
Mazzur
S
Hertzog
K
, et al.
Australia antigen in the Solomon Islands
.
Hum Biol
 
1974
;
46
:
239
262
.
4
Nishioka
K
Levin
AG
Simons
MJ.
Hepatitis B antigen, antigen subtypes, and hepatitis B antibody in normal subjects and patients with liver disease
.
Bull World Health Organ
 
1975
;
52
:
293
300
.
5
Woodfield
DG.
Acute viral hepatitis in Papua New Guinea: results of hepatitis B antigen and antibody studies
.
Trop Geogr Med
 
1975
;
27
:
399
404
.
6
Woodfield
DG.
Hepatitis B infections in expatriate doctors in Papua New Guinea
.
Med J Aust
 
1976
;
2
:
595
599
.
7
Clarke
CW
Woodfield
DG.
Hepatitis B antigen, alpha1 fetoprotein and liver disease in the Eastern Highlands of Papua New Guinea
.
Trop Geogr Med
 
1975
;
27
:
52
58
.
8
Hawkes
RA
Boughton
CR
Ferguson
V.
The seroepidemiology of hepatitis in Papua New Guinea: I. A long-term study of hepatitis A
.
Am J Epidemiol
 
1981
;
114
:
554
562
.
9
Drew
J
London
WT
Blumberg
BS
, et al.
Hepatitis B virus and sex ratio on Kar Kar Island
.
Hum Biol
 
1982
;
54
:
123
135
.
10
Gaxotte
P
Couland
JP
Saimot
J
, et al.
Hepatitis B antigenemia on Wuvulu Island
.
Am J Trop Med Hyg
 
1978
;
27
:
1037
1040
.
11
Wong
DC
Purcell
RH
Rosen
L.
Prevalence of antibody to hepatitis A and hepatitis B viruses in selected populations of the South Pacific
.
Am J Epidemiol
 
1979
;
110
:
227
236
.
12
Hawkes
RA
Boughton
CR
Ferguson
V
, et al.
The seroepidemiology of hepatitis in Papua New Guinea: II. A long-term study of hepatitis B
.
Am J Epidemiol
 
1981
;
114
:
563
573
.
13
Anonymous.
Operation world. The day-by-day guide to praying for the world
. Harrisonburg, Virginia :
R. R. Donnelley & Sons
,
1993
:
1
.
14
Cline
AL
Mosley
JW
Scovel
FG.
Viral hepatitis among American missionaries abroad: a preliminary study
.
JAMA
 
1967
;
199
:
551
553
.
15
Lange
WR
Kreider
SD
Kaczaniuk
MA
, et al.
Missionary health: the great omission
.
Am J Prev Med
 
1987
;
3
:
332
338
.
16
ACP Task Force on Adult Immunization,
Infectious Diseases Society of America. Guide for adult immunization
. Philadelphia :
American College of Physicians
,
1994
:
1
.
17
Margolis
HS
Shapiro
CN.
Considerations for the development of recommendations for the use of hepatitis A vaccine
.
J Hepatol
 
1993
;
18
:
S56
S60
.
18
Lange
WR
Frame
JD.
High incidence of viral hepatitis among American missionaries in Africa
.
Am J Trop Med Hyg
 
1990
;
43
:
527
533
.
19
Ellis
RW
, ed.
Hepatitis B vaccines in clinical practice
. New York :
Marcel Dekker, Inc
,
1993
:
1
.
20
Gardner
P
Eickhoff
T
Poland
GA
, et al.
Update: adult immunizations
.
Ann Intern Med
 
1996
;
124
:
35
40
.
21
Werzberger
A
Mensch
B
Kuter
B
, et al.
A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children
.
N Engl J Med
 
1992
;
327
:
453
457
.
22
Innis
BL
Snitbhan
R
Kunasol
P
, et al.
Protection against hepatitis A by an inactivated vaccine
.
JAMA
 
1994
;
271
:
1328
1334
.
23
Westblom
TU
Gudipati
S
DeRousse
C
, et al.
Safety and immunogenicity of an inactivated hepatitis A vaccine: effect of dose and vaccination schedule
.
J Infect Dis
 
1994
;
169
:
996
1001
.
24
Clemens
R
Safary
A
Hepburn
A
, et al.
Clinical experience with an inactivated hepatitis A vaccine
.
J Infect Dis
 
1995
;
171
:
S44
S49
.
25
Balcarek
KB
Bagley
MR
Pass
RF
, et al.
Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children
.
J Infect Dis
 
1995
;
171
:
S70
S72
.
Dr. Poland is a Mayo Rappaport Scholar.
Portions of this material were presented at the Infectious Disease Society of America (New Orleans, Louisiana, October 1993) and the National Immunization Conference (Washington, DC, June 1993).